Pharmacophore mapping based inhibitor selection and molecular interaction studies for identification of potential drugs on calcium activated potassium channel blockers, tamulotoxin
- PMID:23772102
- PMCID: PMC3680861
- DOI: 10.4103/0973-1296.111239
Pharmacophore mapping based inhibitor selection and molecular interaction studies for identification of potential drugs on calcium activated potassium channel blockers, tamulotoxin
Abstract
Background: Tamulotoxin (TmTx) from Buthus tamulus was found to be a highly venomous toxin which accelerates the neurotransmitter release that directly affects the cardiovascular tissues and the respiratory system leading to death. TmTx from red Indian scorpion is a crucial inhibitor for Ca(2+) activated K(+) channel in humans.
Objective: The study is aimed at the identification of potential inhibitors of TmTx through pharmacophore based inhibitor screening and understanding the molecular level interactions.
Materials and method: The potential inhibitors for TmTx were identified using pharmacophore model based descriptor information present in existing drugs with the analysis of pharmacokinetic properties. The compounds with good ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) descriptors were subjected to molecular interaction studies. The stability of bound toxin-inhibitor complex was studied using molecular dynamics simulation over a period of one nanosecond.
Results: From a dataset of 3406 compounds, few compounds were selected as potential inhibitors based on the generated best pharmacophore models, pharmacokinetic analysis, molecular docking and molecular dynamics studies.
Conclusion: In conclusion, two compounds containing better inhibition properties against TmTx are suggested to be better lead molecules for drug development in future and this study will help us to explore more inhibitors from natural origin against tamulotoxin.
Keywords: Absorption; Distribution; Excretion and Toxicity; HipHop; Metabolism; ion channels; molecular docking; pharmacophore; tamulotoxin.
Conflict of interest statement
Figures
Similar articles
- Pharmacophore modeling, in silico screening, molecular docking and molecular dynamics approaches for potential alpha-delta bungarotoxin-4 inhibitors discovery.Kumar RB, Suresh MX, Priya BS.Kumar RB, et al.Pharmacogn Mag. 2015 May;11(Suppl 1):S19-28. doi: 10.4103/0973-1296.157670.Pharmacogn Mag. 2015.PMID:26109766Free PMC article.
- In silico analysis of potential inhibitors of Ca(2+) activated K(+) channel blocker, Charybdotoxin-C from Leiurus quinquestriatus hebraeus through molecular docking and dynamics studies.Kumar RB, Priya BS, Suresh MX.Kumar RB, et al.Indian J Pharmacol. 2015 May-Jun;47(3):280-4. doi: 10.4103/0253-7613.157123.Indian J Pharmacol. 2015.PMID:26069365Free PMC article.
- Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations.Zhang Y, Zhang TJ, Tu S, Zhang ZH, Meng FH.Zhang Y, et al.Molecules. 2020 Sep 8;25(18):4094. doi: 10.3390/molecules25184094.Molecules. 2020.PMID:32911607Free PMC article.
- Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.Jana S, Singh SK.Jana S, et al.J Biomol Struct Dyn. 2019 Mar;37(4):944-965. doi: 10.1080/07391102.2018.1444510. Epub 2018 Mar 9.J Biomol Struct Dyn. 2019.PMID:29475408
- Mechanisms of cellular synchronization in the vascular wall. Mechanisms of vasomotion.Matchkov VV.Matchkov VV.Dan Med Bull. 2010 Oct;57(10):B4191.Dan Med Bull. 2010.PMID:21040688Review.
Cited by
- Computational Exploration for Lead Compounds That Can Reverse the Nuclear Morphology in Progeria.Rampogu S, Baek A, Son M, Zeb A, Park C, Kumar R, Lee G, Kim D, Choi Y, Cho Y, Park Y, Park SJ, Lee KW.Rampogu S, et al.Biomed Res Int. 2017;2017:5270940. doi: 10.1155/2017/5270940. Epub 2017 Oct 26.Biomed Res Int. 2017.PMID:29226142Free PMC article.
- Pharmacophore modeling, in silico screening, molecular docking and molecular dynamics approaches for potential alpha-delta bungarotoxin-4 inhibitors discovery.Kumar RB, Suresh MX, Priya BS.Kumar RB, et al.Pharmacogn Mag. 2015 May;11(Suppl 1):S19-28. doi: 10.4103/0973-1296.157670.Pharmacogn Mag. 2015.PMID:26109766Free PMC article.
- In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach.Gandhi T, Melge AR, Gopi Mohan C.Gandhi T, et al.J Adv Res. 2016 Nov;7(6):931-944. doi: 10.1016/j.jare.2016.09.004. Epub 2016 Sep 16.J Adv Res. 2016.PMID:27713840Free PMC article.
References
- Cecilia V, Ramon L, Neil VM, John PA. Calcium-activated potassium channels. Curr Opin Neurobiol. 1998;8:321–9. - PubMed
- Brenner R, Jegla TJ, Wickenden A, Liu Y, Aldrich RW. Cloning and functional characterization of novel large conductance calcium-activated potassium channel beta subunits, hKCNMB3 and hKCNMB4. J Biol Chem. 2000;275:6453–61. - PubMed
- Garcia ML, Galvez A, Garcia-Calvo M, King VF, Vazquez J, Kaczorowski GJ. Use of toxins to study potassium channels. J Bioenerg Biomembr. 1991;23:615–46. - PubMed
- Martin-Eauclaire MF, Couraud F. Scorpion neurotoxins: effects and mechanisms. In: Chang LW, Dyer RS, editors. Handbook of Neurotoxicology. 1995. pp. 683–716.
- Tytgat J, Chandy KG, Garcia ML, Gutman GA, Martin-Eauclaire MF, van der Walt JJ, et al. A unified nomenclature for short-chain peptides isolated from scorpion venoms: Alpha-KTx molecular subfamilies. Trends Pharmacol Sci. 1999;20:444–7. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous